For US residents only.

Monitoring Your Treatment

KISQALI® (ribociclib) + HORMONE THERAPY OR FULVESTRANT

Monitoring KISQALI treatment

Monitoring Your Treatment

Your doctor may conduct certain tests before and during your treatment with KISQALI® (ribociclib) to determine if it's the right option for you. These tests may include:

 

icon-heart Heart Monitoring 

•  Electrocardiogram (ECG or EKG)
: An electrocardiogram, also known as an ECG or EKG, is a test that shows changes in the electrical activity of the heart over time

 

 

icon-blood-dropBlood Tests 

• Electrolytes Panel
: A blood test that measures the main electrolytes in the body—potassium, calcium, phosphorus, and magnesium—to check for an imbalance of the electrolytes or an acid–base imbalance
Complete Blood Count (CBC): A measure of the number of red blood cells, white blood cells, and platelets in the blood. A CBC also measures the amount of hemoglobin (substance in the blood that carries oxygen) and the hematocrit (the amount of whole blood that is made up of red blood cells)
Liver Function Test (LFT): A blood test to measure the blood levels of certain substances released by the liver. A high or low level of certain substances can be a sign of liver disease

 

 

At any time, your health care team may stop, decrease, or tell you to wait to begin your treatment with KISQALI. You should always take KISQALI exactly as your doctor tells you.